A double-blind, placebo-controlled trial of the effect of chronically administered oral acyclovir on sperm production in men with frequently recurrent genital herpes. 1988

J M Douglas, and L G Davis, and M L Remington, and C A Paulsen, and E B Perrin, and P Goodman, and J D Conner, and D King, and L Corey
Department of Laboratory Medicine, School of Medicine, University of Washington, Seattle.

UI MeSH Term Description Entries
D008297 Male Males
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006558 Herpes Genitalis Infection of the genitals (GENITALIA) with HERPES SIMPLEX VIRUS in either the males or the females. Genital Herpes,Herpes Simplex, Genital,Herpes Simplex Virus Genital Infection,Genital Herpes Simplex,Herpes, Genital
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012661 Semen The thick, yellowish-white, viscid fluid secretion of male reproductive organs discharged upon ejaculation. In addition to reproductive organ secretions, it contains SPERMATOZOA and their nutrient plasma. Seminal Plasma,Plasma, Seminal

Related Publications

J M Douglas, and L G Davis, and M L Remington, and C A Paulsen, and E B Perrin, and P Goodman, and J D Conner, and D King, and L Corey
June 1984, The New England journal of medicine,
J M Douglas, and L G Davis, and M L Remington, and C A Paulsen, and E B Perrin, and P Goodman, and J D Conner, and D King, and L Corey
February 1993, Annals of internal medicine,
J M Douglas, and L G Davis, and M L Remington, and C A Paulsen, and E B Perrin, and P Goodman, and J D Conner, and D King, and L Corey
January 1985, Acta dermato-venereologica,
J M Douglas, and L G Davis, and M L Remington, and C A Paulsen, and E B Perrin, and P Goodman, and J D Conner, and D King, and L Corey
October 1991, The Journal of infectious diseases,
J M Douglas, and L G Davis, and M L Remington, and C A Paulsen, and E B Perrin, and P Goodman, and J D Conner, and D King, and L Corey
August 1985, The Journal of antimicrobial chemotherapy,
J M Douglas, and L G Davis, and M L Remington, and C A Paulsen, and E B Perrin, and P Goodman, and J D Conner, and D King, and L Corey
June 1989, Danish medical bulletin,
J M Douglas, and L G Davis, and M L Remington, and C A Paulsen, and E B Perrin, and P Goodman, and J D Conner, and D King, and L Corey
September 1984, JAMA,
J M Douglas, and L G Davis, and M L Remington, and C A Paulsen, and E B Perrin, and P Goodman, and J D Conner, and D King, and L Corey
August 1988, The American journal of medicine,
J M Douglas, and L G Davis, and M L Remington, and C A Paulsen, and E B Perrin, and P Goodman, and J D Conner, and D King, and L Corey
September 1988, The American journal of medicine,
J M Douglas, and L G Davis, and M L Remington, and C A Paulsen, and E B Perrin, and P Goodman, and J D Conner, and D King, and L Corey
April 1984, JAMA,
Copied contents to your clipboard!